STOCK TITAN

KIDOZ INC Form 4 Filings

KDOZF OTC

Every Form 4 that KIDOZ INC (KDOZF) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A Form 4 covers the transactions officers, directors and large holders report, so if you follow KDOZF and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full KDOZF filings page.

Rhea-AI Summary

KIDOZ INC. (KDOZF) director, chairman, and ten percent owner Tryon M. Williams reported open-market or private purchases of a total of 15,000 shares of Common Stock on September 4, 8, and 9, 2026, at prices between $0.094 and $0.1087 per share.

Williams also reports direct holdings of several employee stock options to acquire Common Stock, covering 150,000 shares at $0.39, 50,000 shares at $0.22, 168,750 shares at $0.147, and 50,000 shares at $0.18, plus an indirect holding of 2,877,465 Common shares through a discretionary trust.

Rhea-AI Summary

KIDOZ Inc. Chief Strategy Officer and director Eldad Ben Tora purchased 5,000 shares of common stock on July 23, 2026 at US$0.1010 per share, increasing his direct holdings to 5,219,965 shares.

He also holds several employee stock option grants on additional common shares with exercise prices between 0.1470 and 0.3900.

Rhea-AI Summary

Kidoz Inc. chairman and ten percent owner Tryon M. Williams purchased 2,500 shares of common stock on July 16, 2026 at approximately US$0.1175 per share, increasing his direct holdings to 16,625,066 shares. He also holds several employee stock option grants, including options on 150,000 shares at US$0.39 and 168,750 shares at US$0.147 per share, alongside other smaller grants.

Rhea-AI Summary

Kidoz Inc. director David Moshe reported an expiration of 50,000 employee stock options with an exercise price of approximately US$0.81 on April 6, 2026, which lapsed unexercised. He continues to hold common shares directly and indirectly, along with multiple remaining stock option grants at lower exercise prices.

Rhea-AI Summary

KIDOZ INC. director Claes Kalborg reported the expiration of 50,000 employee stock options on common shares. The options, with an exercise price of approximately US$0.81 per share (CAD$1.02), expired unexercised on April 6, 2026.

After this expiration, Kalborg continues to hold several option grants on KIDOZ common stock: 50,000 options at about US$0.39 per share expiring on February 1, 2027, 50,000 at about US$0.22 expiring on February 21, 2028, 231,250 at US$0.147 expiring on March 25, 2029, and 50,000 at about US$0.18 expiring on August 21, 2030.

Rhea-AI Summary

Kidoz Inc. director Fiona Mary Curtis reported an expiration of employee stock options with no share purchases or sales. On April 6, 2026, 50,000 options with an exercise price of approximately US$0.81 expired unexercised. She continues to hold several option grants over common stock at exercise prices ranging from approximately US$0.147 to US$0.39, covering 150,000, 50,000, 168,750 and 50,000 underlying shares with expirations between 2027 and 2030. She also holds 50,000 common shares directly.

Rhea-AI Summary

KIDOZ INC. director and officer Eldad Ben Tora reported that 50,000 employee stock options with an exercise price of about US$0.81 expired unexercised. He continues to hold 5,214,965 common shares directly, along with several remaining option grants at lower exercise prices and later expiration dates.

Rhea-AI Summary

Kidoz Inc. Chief Executive Officer Jason Miles Williams reported the expiration of 50,000 employee stock options on April 6, 2026. These options had an exercise price of approximately US$0.81 and expired unexercised, removing that block of potential share purchases.

Following this expiration, Williams directly holds 908,200 shares of Kidoz common stock. He also retains several option grants over a total of 418,750 underlying shares at lower exercise prices between approximately US$0.147 and US$0.39, with expirations from 2027 through 2030. Several of these grants vest at a rate of 2% per month.

Rhea-AI Summary

KIDOZ INC. Chief Financial Officer Henry Walford Bromley reported that 50,000 employee stock options with an exercise price of approximately US$0.81 per share expired unexercised. These options related to Kidoz Inc. shares and reached their expiration date without being converted into common stock.

Following this expiration, he continues to hold 375,000 common shares directly, along with multiple remaining employee stock option grants on Kidoz common stock at lower exercise prices and later expiration dates.

Rhea-AI Summary

KIDOZ INC. director, officer and 10% owner Tryon M. Williams reported that 50,000 employee stock options with an exercise price of about US$0.81 expired unexercised on April 6, 2026. This expiration did not involve any share purchases or sales.

Following this, Williams continues to hold option grants over 418,750 shares of common stock at lower exercise prices ranging from about US$0.18 to US$0.39, with expirations between 2027 and 2030. He also reports direct ownership of 16,622,566 common shares and indirect ownership of 2,877,465 common shares through a discretionary trust.

Rhea-AI Summary

KIDOZ INC. chairman and 10% owner Tryon M. Williams bought 2,000 shares of common stock in an open-market transaction at approximately US$0.232 per share on March 10, 2026. Following the purchase, he directly owns 16,622,566 common shares.

He also has indirect ownership of 2,877,465 common shares through a discretionary trust and holds several employee stock option awards, including 50,000 options exercisable at US$0.81, 150,000 at US$0.39, 50,000 at US$0.22, 168,750 at US$0.147, and 50,000 at US$0.18, with expiration dates ranging from 2026 to 2030.

Rhea-AI Summary

KIDOZ INC. Chairman and major shareholder Tryon M. Williams bought 2,000 shares of common stock in an open‑market purchase at $0.228 per share on March 9, 2026. After this trade, he directly owns 16,620,566 common shares. He also holds several employee stock option awards, including grants with exercise prices between $0.147 and $0.81 per share that are scheduled to expire from 2026 through 2030. In addition to his direct stake, 2,877,465 common shares are reported as indirectly owned through a discretionary trust.

Rhea-AI Summary

KIDOZ INC. chairman and 10% owner Tryon M. Williams reported an open-market purchase of 8,000 common shares on March 6, 2026 at approximately US$0.228 per share. Following this transaction, he directly holds 16,618,566 common shares.

He also reports direct holdings of employee stock options covering 50,000, 150,000, 50,000, 168,750 and 50,000 shares, granted between April 2021 and August 2025 at exercise prices from CAD$0.20 to CAD$1.02. In addition, an indirect holding of 2,877,465 common shares is listed through a discretionary trust.

Rhea-AI Summary

KIDOZ INC. chairman and 10% owner Tryon M. Williams bought 2,000 common shares on March 4, 2026 in an open‑market purchase at US$0.223 per share (about CAD$0.305). After this trade, he directly owned 16,610,566 common shares.

Williams also reports several previously granted employee stock options, including blocks of 50,000, 150,000, 50,000, 168,750, and 50,000 options with exercise prices between CAD$0.20 and CAD$1.02, most vesting at 2% per month. A discretionary trust associated with him indirectly holds 2,877,465 common shares.

Rhea-AI Summary

KIDOZ INC. chairman and 10% owner Williams Tryon M reported an open-market purchase of 5,000 common shares at approximately US$0.249 per share on March 3, 2026, bringing his direct holdings to 16,608,566 shares. He also reports 2,877,465 common shares held through a discretionary trust and several prior stock option grants with exercise prices between CAD$0.20 and CAD$1.02 that vest at 2% per month where stated.

Rhea-AI Summary

Kidoz Inc. director Moshe David reported an expiration of stock options and updated share holdings. On February 1, 2026, 50,000 employee stock options with an exercise price of approximately US$0.39 expired unexercised. Following this, he beneficially owns 445,000 stock options across several grants with different exercise prices and maturities.

He also reports ownership of 543,379 Kidoz common shares directly, and an additional 339,612 common shares held indirectly through Compass H.N.T Yazamut Ltd., a company that is 100% owned by him.

Rhea-AI Summary

Kidoz Inc. president and general manager Eldad Ben Tora filed a Form 4 detailing stock option activity and current holdings. On February 1, 2026, 50,000 employee stock options with a US$0.39 exercise price expired unexercised. Following this, he directly holds 5,214,965 Kidoz common shares and 445,000 employee stock options across several grants with exercise prices ranging from approximately US$0.147 to US$0.813, many vesting at 2% per month.

Rhea-AI Summary

Kidoz Inc. director Claes Kalborg reported an update to his stock option holdings. On February 1, 2026, 50,000 employee stock options with an exercise price of approximately US$0.39 expired unexercised, recorded with transaction code "E" for an expiration event.

After this change, Kalborg beneficially owns a total of 431,250 employee stock options in Kidoz Inc., all held directly. These options come from several prior grants between 2021 and 2025, with exercise prices ranging from approximately US$0.147 to US$0.813 and expirations from 2026 through 2030. The footnotes state that the grants generally vest at a rate of 2% per month, reflecting ongoing vesting schedules tied to his role with the company.

Rhea-AI Summary

Kidoz Inc. director Fiona Mary Curtis reported the expiration of 50,000 employee stock options on February 1, 2026. These options had an exercise price of CAD$0.50 (approximately US$0.39) and expired unexercised. Following this event, she directly holds 468,750 employee stock options across several grants with exercise prices ranging from CAD$0.20 to CAD$1.02, all vesting at 2% per month where stated. She also directly holds 50,000 shares of Kidoz Inc. common stock.

Rhea-AI Summary

Kidoz Inc. director and CEO Jason Miles Williams reported an update to his holdings. On February 1, 2026, 50,000 employee stock options with an exercise price of approximately US$0.39 expired unexercised, coded as an "E" transaction.

Following this expiration, Williams directly holds 468,750 employee stock options across several grants with exercise prices ranging from approximately US$0.147 to US$0.81, with various vesting schedules. He also directly owns 908,200 shares of Kidoz Inc. common stock.

Rhea-AI Summary

Kidoz Inc. chairman and 10% owner T. M. Williams reported an update to his equity holdings. On February 1, 2026, 50,000 employee stock options with an exercise price of approximately US$0.39 expired unexercised. Following this, he holds 468,750 employee stock options across several grants with exercise prices ranging from approximately US$0.147 to US$0.81.

Williams also reports ownership of 16,603,566 shares of Kidoz common stock directly and 2,877,465 shares indirectly through a discretionary trust as of the reported date. This filing mainly refreshes the public record of his stock and option positions.

Rhea-AI Summary

Kidoz Inc. Chief Financial Officer H. W. Bromley reported the expiration of 50,000 employee stock options on February 1, 2026. These options had an exercise price of about US$0.39 and expired unexercised at the end of their term.

Following this event, Bromley directly holds 375,000 shares of Kidoz common stock and 468,750 employee stock options across several grants, with exercise prices ranging from about US$0.147 to US$0.813 and expiration dates between 2026 and 2030.